Products

What will AGI do for Aliflurane?

This classification denotes an anesthetic agent with the molecular formula C4H3ClF4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q1069WKM8G, chemically known as 2-chloro-1,2,3,3-tetrafluorocyclopropyl methyl ether but generally known as aliflurane, which bears US NIH Compound Identifier 41967. European Medicines Agency schedules Aliflurane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05326MIG. The term ALIFLURANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). ALIFLURANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aliflurane under HS 29092000 and SITC 51616. As of Q4 2014, ALIFLURANE remains the US FDA Preferred Term for this commodity. Aliflurane bears US NLM identifiers UMLS ID C0051159 and NCI Concept Code C75082. SMILES: CLC1(F)C(F)(OC)C1(F)F.

How AGI delivers it

Four ways AGI delivers for Aliflurane

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aliflurane, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aliflurane, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aliflurane connects

measured by

  • Assay Puritymodel
  • Boiling Pointmodel
  • Moisture Contentmodel
  • Refractive Indexmodel